{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:44:43Z","timestamp":1784861083951,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:00:00Z","timestamp":1546473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12028-018-0657-y","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T10:43:36Z","timestamp":1546512216000},"page":"116-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5483-8007","authenticated-orcid":false,"given":"S.","family":"Piva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Galeotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ceccherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cordoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Signorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Togni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"De Nicol\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Rasulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazzareno","family":"Fagoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Latronico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"D\u2019Avolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,3]]},"reference":[{"issue":"11","key":"657_CR1","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s00415-008-0059-8","volume":"255","author":"R Beer","year":"2008","unstructured":"Beer R, Lackner P, Pfausler B, Schmutzhard E. Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol. 2008;255(11):1617\u201324.","journal-title":"J Neurol"},{"issue":"5","key":"657_CR2","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3109\/02688697.2011.578770","volume":"25","author":"WJ Kitchen","year":"2011","unstructured":"Kitchen WJ, Singh N, Hulme S, Galea J, Patel HC, King AT. External ventricular drain infection: improved technique can reduce infection rates. Br J Neurosurg. 2011;25(5):632\u20135.","journal-title":"Br J Neurosurg"},{"issue":"Suppl 2","key":"657_CR3","first-page":"688","volume":"62","author":"AP Lozier","year":"2008","unstructured":"Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2008;62(Suppl 2):688\u2013700.","journal-title":"Neurosurgery"},{"issue":"Suppl 2","key":"657_CR4","first-page":"532","volume":"62","author":"A-M Korinek","year":"2008","unstructured":"Korinek A-M, Baugnon T, Golmard J-L, van Effenterre R, Coriat P, Puybasset L. Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis. Neurosurgery. 2008;62(Suppl 2):532\u20139.","journal-title":"Neurosurgery"},{"issue":"5","key":"657_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jinf.2012.12.010","volume":"66","author":"LN Walti","year":"2013","unstructured":"Walti LN, Conen A, Coward J, Jost GF, Trampuz A. Characteristics of infections associated with external ventricular drains of cerebrospinal fluid. J Infect. 2013;66(5):424\u201331.","journal-title":"J Infect"},{"issue":"1","key":"657_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00006123-200207000-00024","volume":"51","author":"AP Lozier","year":"2002","unstructured":"Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2002;51(1):170\u20132.","journal-title":"Neurosurgery"},{"issue":"1","key":"657_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s15010-010-0073-5","volume":"39","author":"EF Camacho","year":"2011","unstructured":"Camacho EF, Boszczowski I, Basso M, et al. Infection rate and risk factors associated with infections related to external ventricular drain. Infection. 2011;39(1):47\u201351.","journal-title":"Infection"},{"issue":"5","key":"657_CR8","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3171\/jns.2003.98.5.1040","volume":"98","author":"B Pfausler","year":"2003","unstructured":"Pfausler B, Spiss H, Beer R, et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg. 2003;98(5):1040\u20134.","journal-title":"J Neurosurg"},{"issue":"6","key":"657_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/cid\/cix152","volume":"64","author":"AR Tunkel","year":"2017","unstructured":"Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64(6):701\u20136.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"657_CR10","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1093\/jac\/dkh158","volume":"53","author":"B Pfausler","year":"2004","unstructured":"Pfausler B, Spiss H, Dittrich P, Zeitlinger M, Schmutzhard E, Joukhadar C. Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis. J Antimicrob Chemother. 2004;53(5):848\u201352.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"657_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1128\/AAC.00515-06","volume":"51","author":"R Beer","year":"2007","unstructured":"Beer R, Engelhardt KW, Pfausler B, et al. Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains. Antimicrob Agents Chemother. 2007;51(1):379\u201382.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"657_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1179\/joc.2007.19.1.90","volume":"19","author":"P Malacarne","year":"2007","unstructured":"Malacarne P, Viaggi B, Di Paolo A, Danesi R, Del Tacca M. Linezolid cerebrospinal fluid concentration in central nervous system infection. J Chemother. 2007;19(1):90\u20133.","journal-title":"J Chemother"},{"issue":"12","key":"657_CR13","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1128\/AAC.00051-06","volume":"50","author":"P Myrianthefs","year":"2006","unstructured":"Myrianthefs P, Markantonis SL, Vlachos K, et al. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother. 2006;50(12):3971\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"657_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1345\/aph.1H307","volume":"41","author":"F Ntziora","year":"2007","unstructured":"Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother. 2007;41(2):296\u2013308.","journal-title":"Ann Pharmacother"},{"issue":"12","key":"657_CR15","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1086\/420818","volume":"38","author":"RD Arbeit","year":"2004","unstructured":"Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI. Daptomycin 98-01 and 99-01 investigators. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis. 2004;38(12):1673\u201381.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"657_CR16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"VG Fowler","year":"2006","unstructured":"Fowler VG, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355(7):653\u201365.","journal-title":"N Engl J Med"},{"issue":"2","key":"657_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000109868","volume":"81","author":"R Sauermann","year":"2008","unstructured":"Sauermann R, Rothenburger M, Graninger W, Joukhadar C. Daptomycin: a review 4\u00a0years after first approval. Pharmacology. 2008;81(2):79\u201391.","journal-title":"Pharmacology"},{"issue":"10","key":"657_CR18","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1128\/AAC.00247-06","volume":"50","author":"M Benvenuto","year":"2006","unstructured":"Benvenuto M, Benziger DP, Yankelev S, Vigliani G. Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother. 2006;50(10):3245\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"657_CR19","doi-asserted-by":"publisher","first-page":"593578","DOI":"10.1155\/2012\/593578","volume":"2012","author":"M Erritouni","year":"2012","unstructured":"Erritouni M, Ktaich N, Rahal JJ, et al. Use of daptomycin for the treatment of methicillin-resistant coagulase-negative staphylococcal ventriculitis. Case Rep Med. 2012;2012:593578.","journal-title":"Case Rep Med"},{"issue":"3","key":"657_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.diagmicrobio.2011.07.001","volume":"71","author":"T Kelesidis","year":"2011","unstructured":"Kelesidis T, Humphries R, Ward K, Lewinski MA, Yang OO. Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia. Diagn Microbiol Infect Dis. 2011;71(3):286\u201390.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"657_CR21","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1345\/aph.1P333","volume":"44","author":"J Le","year":"2010","unstructured":"Le J, Bookstaver PB, Rudisill CN, et al. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy. Ann Pharmacother. 2010;44(12):2001\u20136.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"657_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.diagmicrobio.2013.01.021","volume":"76","author":"A Vena","year":"2013","unstructured":"Vena A, Falcone M, Comandini E, et al. Daptomycin plus trimethoprim\/sulfamethoxazole combination therapy in post-neurosurgical meningitis caused by linezolid-resistant Staphylococcus epidermidis. Diagn Microbiol Infect Dis. 2013;76(1):99\u2013102.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"657_CR23","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1345\/aph.1R412","volume":"46","author":"SW Mueller","year":"2012","unstructured":"Mueller SW, Kiser TH, Anderson TA, Neumann RT. Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus Faecium. Ann Pharmacother. 2012;46(12):e35.","journal-title":"Ann Pharmacother"},{"issue":"7","key":"657_CR24","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1128\/AAC.01741-10","volume":"55","author":"R Kullar","year":"2011","unstructured":"Kullar R, Chin JN, Edwards DJ, Parker D, Coplin WM, Rybak MJ. Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections. Antimicrob Agents Chemother. 2011;55(7):3505\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"657_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309\u201332.","journal-title":"Am J Infect Control"},{"key":"657_CR26","unstructured":"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process\n                    \n                  . Accessed 20 Oct 2018."},{"issue":"2","key":"657_CR27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00216-009-3263-1","volume":"396","author":"L Baietto","year":"2010","unstructured":"Baietto L, D\u2019Avolio A, De Rosa FG, et al. Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma. Anal Bioanal Chem. 2010;396(2):791\u20138.","journal-title":"Anal Bioanal Chem"},{"key":"657_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jpba.2013.08.022","volume":"88","author":"L Baietto","year":"2014","unstructured":"Baietto L, D\u2019Avolio A, Pace S, et al. Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots. J Pharm Biomed Anal. 2014;88:66\u201370.","journal-title":"J Pharm Biomed Anal"},{"key":"657_CR29","unstructured":"https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm070107.Pdf\n                    \n                  . Accessed 31 Oct 2018."},{"issue":"3","key":"657_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ijantimicag.2013.06.006","volume":"42","author":"A Paolo Di","year":"2013","unstructured":"Di Paolo A, Tascini C, Polillo M, et al. Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections. Int J Antimicrob Agents. 2013;42(3):250\u20135.","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"657_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40262-013-0062-9","volume":"52","author":"A Paolo Di","year":"2013","unstructured":"Di Paolo A, Gori G, Tascini C, Danesi R, Del Tacca M. Clinical pharmacokinetics of antibacterials in cerebrospinal fluid. Clin Pharmacokinet. 2013;52(7):511\u201342.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"657_CR32","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1093\/cid\/ciu230","volume":"58","author":"A Paolo Di","year":"2014","unstructured":"Di Paolo A, Polillo M, Tascini C, Lewis R, Menichetti F, Danesi R. Different recommendations for daptomycin dosing over time in patients with severe infections. Clin Infect Dis. 2014;58(12):1788\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"657_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijantimicag.2015.01.014","volume":"46","author":"M Vivas","year":"2015","unstructured":"Vivas M, Force E, Tubau F, El Haj C, Ariza J, Cabellos C. Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis. Int J Antimicrob Agents. 2015;46(1):28\u201332.","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"657_CR34","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1093\/cid\/cit582","volume":"57","author":"M Falcone","year":"2013","unstructured":"Falcone M, Russo A, Venditti M, Novelli A, Pai MP. Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2013;57(11):1568\u201376.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"657_CR35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1177\/0091270004266619","volume":"44","author":"B Dvorchik","year":"2004","unstructured":"Dvorchik B. Moderate liver impairment has no influence on daptomycin pharmacokinetics. J Clin Pharmacol. 2004;44(7):715\u201322.","journal-title":"J Clin Pharmacol"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-018-0657-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-018-0657-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-018-0657-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T19:28:58Z","timestamp":1577993338000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-018-0657-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["657"],"URL":"https:\/\/doi.org\/10.1007\/s12028-018-0657-y","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,3]]},"assertion":[{"value":"3 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that they do not have any Competing Interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the institutional review board (Spedali Civili di Brescia, university of Brescia; IRB1723). Written informed consent was obtained from patients or their legal representatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The dataset is available in Github repository, .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}}]}}